Mechanism of action of 5-HT3 receptor antagonists: clinical overview and nursing implications.
Research has shown that the emetic response is linked to serotonin and the stimulation of the 5-HT3 receptors located in several areas of the body. Consequently, 5-HT3 receptor antagonists have been developed, and many studies have demonstrated their efficacy in controlling chemotherapy-induced nausea and vomiting. Oral formulations of 5-HT3 receptor antagonists are often equally or more effective than i.v. antiemetic regimens and are well tolerated and convenient. Adverse effects associated with the 5-HT3 receptor antagonists are generally mild to moderate in severity and transient in nature. A thorough patient assessment combined with a multidisciplinary approach that involves patients, nurses, physicians, and pharmacists optimizes antiemetic therapy.